Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins.

14-3-3s Hereditary spastic paraplegia (HSP) Intracellular trafficking Protein Kinase A (PKA) Protein-protein interactions (PPI) SPG11/Spatacsin

Journal

Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 23 05 2022
revised: 06 09 2022
accepted: 08 09 2022
pubmed: 13 9 2022
medline: 2 11 2022
entrez: 12 9 2022
Statut: ppublish

Résumé

Mutations in SPG11, encoding spatacsin, constitute the major cause of autosomal recessive Hereditary Spastic Paraplegia (HSP) with thinning of the corpus callosum. Previous studies showed that spatacsin orchestrates cellular traffic events through the formation of a coat-like complex and its loss of function results in lysosomal and axonal transport impairments. However, the upstream mechanisms that regulate spatacsin trafficking are unknown. Here, using proteomics and CRISPR/Cas9-mediated tagging of endogenous spatacsin, we identified a subset of 14-3-3 proteins as physiological interactors of spatacsin. The interaction is modulated by Protein Kinase A (PKA)-dependent phosphorylation of spatacsin at Ser1955, which initiates spatacsin trafficking from the plasma membrane to the intracellular space. Our study provides novel insight in understanding spatacsin physio-pathological roles with mechanistic dissection of its associated pathways.

Identifiants

pubmed: 36096339
pii: S0969-9961(22)00250-9
doi: 10.1016/j.nbd.2022.105858
pii:
doi:

Substances chimiques

14-3-3 Proteins 0
Cyclic AMP-Dependent Protein Kinases EC 2.7.11.11
SPG11 protein, human 0
Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105858

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M017222/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N026004/1
Pays : United Kingdom

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflict of interest.

Auteurs

Susanna Cogo (S)

Department of Biology, University of Padova, Padova, Italy; School of Biological Sciences, University of Reading, United Kingdom. Electronic address: s.cogo@reading.ac.uk.

James E Tomkins (JE)

School of Pharmacy, University of Reading, Reading, United Kingdom; Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, United Kingdom.

Nikoleta Vavouraki (N)

School of Pharmacy, University of Reading, Reading, United Kingdom; Department of Mathematics and Statistics, University of Reading, Reading, United Kingdom.

Veronica Giusti (V)

Department of Biology, University of Padova, Padova, Italy.

Federica Forcellato (F)

Department of Biology, University of Padova, Padova, Italy.

Cinzia Franchin (C)

Department of Biomedical Sciences, University of Padova, Padova, Italy.

Isabella Tessari (I)

Department of Biology, University of Padova, Padova, Italy.

Giorgio Arrigoni (G)

Department of Biomedical Sciences, University of Padova, Padova, Italy.

Laura Cendron (L)

Department of Biology, University of Padova, Padova, Italy.

Claudia Manzoni (C)

School of Pharmacy, University College London, London, United Kingdom.

Laura Civiero (L)

Department of Biology, University of Padova, Padova, Italy; IRCCS San Camillo Hospital, Venice, Italy; Centro Studi per la Neurodegenerazione (CESNE), University of Padova, Italy.

Patrick A Lewis (PA)

School of Pharmacy, University of Reading, Reading, United Kingdom; Department of Comparative Biomedical Sciences, Royal Veterinary College, London, United Kingdom; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, United Kingdom.

Elisa Greggio (E)

Department of Biology, University of Padova, Padova, Italy; Centro Studi per la Neurodegenerazione (CESNE), University of Padova, Italy. Electronic address: elisa.greggio@unipd.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH